This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Asama Chemical Co., Ltd.. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Hiroichi Katsuyama: Innovator in Immunomodulation
Introduction
Hiroichi Katsuyama is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of immunomodulation, particularly through his innovative patent that focuses on the administration of DNA for health benefits. His work aims to provide alternative methods for delivering immunomodulators, making them more accessible for daily use.
Latest Patents
Katsuyama holds a patent for an immunomodulator, immunomodulator food, and immunomodulator feed. This patent introduces a method for administering DNA orally or percutaneously, rather than through traditional injection methods. The immunomodulator is derived from procaryotic cells, such as lactic acid bacteria and amino acid-producing bacteria, and can be incorporated into food or feed products. This innovation allows for a more convenient and user-friendly approach to health supplementation.
Career Highlights
Katsuyama's career is marked by his dedication to advancing health technologies. His work at Asama Chemical Co., Ltd. has positioned him as a key player in the development of novel immunomodulatory solutions. His focus on practical applications of scientific research has led to significant advancements in the field.
Collaborations
Katsuyama collaborates with esteemed colleagues, including Yasuki Fukuda and Kousaku Murata. Their combined expertise fosters an environment of innovation and creativity, driving forward the research and development of new health products.
Conclusion
Hiroichi Katsuyama's contributions to immunomodulation through his innovative patent reflect his commitment to improving health solutions. His work continues to inspire advancements in the field, making a lasting impact on health and wellness.